tiprankstipranks
Trending News
More News >
MapLight Therapeutics, Inc. (MPLT)
NASDAQ:MPLT
US Market
Advertisement

MapLight Therapeutics, Inc. (MPLT) Ownership - Who Owns MapLight Therapeutics, Inc.?

Compare
4 Followers

MapLight Therapeutics, Inc. (MPLT) Ownership Overview

53.58%0.11%46.31%
53.58%
Insiders
0.11% ETFs
46.31% Public Companies and
Individual Investors
The ownership structure of MapLight Therapeutics, Inc. (MPLT) stock is a mix of institutional, retail, and individual investors. , 53.58% is owned by Insiders, and 46.31% is owned by Public Companies and Individual Investors.
The ownership structure of MapLight Therapeutics, Inc. (MPLT) stock is a mix of institutional, retail, and individual investors. Approximately 46.42% of the company’s stock is owned by Institutional Investors, 53.58% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns MapLight Therapeutics, Inc. (MPLT)?
Currently, no data Available
What percentage of MapLight Therapeutics, Inc. (MPLT) stock is held by institutional investors?
Currently, no data Available
What percentage of MapLight Therapeutics, Inc. (MPLT) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.31% of MapLight Therapeutics, Inc. (MPLT) stock is held by retail investors.
    Who owns the most shares of MapLight Therapeutics, Inc. (MPLT)?
    Currently, no data Available
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis